Novartis AG to Discuss the Zolgensma® Update Call Transcript
Thank you very much, and thank you very much to everybody who's participating on the call today.
Before we begin, I'll just read the safe harbor statement. The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties and other factors. These may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Please refer to the company's Form 20-F on file with the U.S. Securities and Exchange Commission for a description of some of these factors.
And with that, I'll hand across to Vas.
Thank you, Samir. And thanks for everyone for joining today's call. We're here to provide you an update and answer your questions regarding FDA's recent communication on Zolgensma. I'll go through a few opening points, and then we'll open the line for questions.
First and foremost, we are fully confident in the safety, quality and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
